Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3646 AL 3660

The cellular and molecular processes associated with scopolamine-induced memory deficit: A model of Alzheimer's biomarkers

Tang KS.

Life Sci. 2019 Sep 15;233:116695. doi: 10.1016/j.lfs.2019.116695. Epub 2019 Jul 25.

Amyloid-β PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic

Müller EG, Edwin TH, Stokke C, Navelsaker SS, Babovic A, Bogdanovic N, Knapskog AB, Revheim ME.

PLoS One. 2019 Aug 20;14(8):e0221365. doi: 10.1371/journal.pone.0221365. eCollection 2019.

The "rights" of precision drug development for Alzheimer's disease

Cummings J, Feldman HH, Scheltens P.

Alzheimers Res Ther. 2019 Aug 31;11(1):76. doi: 10.1186/s13195-019-0529-5.

Developing Effective Alzheimer's Disease Therapies: Clinical Experience and Future Directions

Elmaleh DR, Farlow MR, Conti PS, Tompkins RG, Kundakovic L, Tanzi RE.

J Alzheimers Dis. 2019;71(3):715-732. doi: 10.3233/JAD-190507.

A Pilot Study of Exenatide Actions in Alzheimer's Disease

Mullins RJ, Mustapic M, Chia CW, Carlson O, Gulyani S, Tran J, Li Y, Mattson MP, Resnick S, Egan JM, Greig NH, Kapogiannis D.

Curr Alzheimer Res. 2019;16(8):741-752. doi: 10.2174/1567205016666190913155950.

Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation

Ruthirakuhan M, Herrmann N, Andreazza AC, Verhoeff NPLG, Gallagher D, Black SE, Kiss A, Lanctôt KL.

J Geriatr Psychiatry Neurol. 2020 Jul;33(4):175-184. doi: 10.1177/0891988719874118. Epub 2019 Sep 23.

A New Kid on the Block? Carbonic Anhydrases as Possible New Targets in Alzheimer's Disease

Provensi G, Carta F, Nocentini A, Supuran CT, Casamenti F, Passani MB, Fossati S.

Int J Mol Sci. 2019 Sep 24;20(19):4724. doi: 10.3390/ijms20194724.

Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4(-/-): A double-blind, randomized, placebo-controlled crossover trial

Xu Q, Zhang Y, Zhang X, Liu L, Zhou B, Mo R, Li Y, Li H, Li F, Tao Y, Liu Y, Xue C.

Clin Nutr. 2020 Jul;39(7):2092-2105. doi: 10.1016/j.clnu.2019.10.017. Epub 2019 Oct 22.

Macroalgae as a Valuable Source of Naturally Occurring Bioactive Compounds for the Treatment of Alzheimer's Disease

Olasehinde TA, Olaniran AO, Okoh AI.

Mar Drugs. 2019 Oct 25;17(11):609. doi: 10.3390/md17110609.

Neutral Endopeptidase (Neprilysin) in Therapy and Diagnostics: Yin and Yang

Feygina EE, Katrukha AG, Semenov AG.

Biochemistry (Mosc). 2019 Nov;84(11):1346-1358. doi: 10.1134/S0006297919110105.

Alzheimer's Disease and NQO1: Is there a Link?

Chhetri J, King AE, Gueven N.

Curr Alzheimer Res. 2018;15(1):56-66. doi: 10.2174/1567205014666170203095802.

Genetic Heterogeneity of Alzheimer's Disease: Embracing Research Partnerships

Nacmias B, Bagnoli S, Piaceri I, Sorbi S.

J Alzheimers Dis. 2018;62(3):903-911. doi: 10.3233/JAD-170570.

The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease

Tamagno E, Guglielmotto M, Monteleone D, Manassero G, Vasciaveo V, Tabaton M.

J Alzheimers Dis. 2018;62(3):1241-1245. doi: 10.3233/JAD-170581.

Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer's Disease: Are There Methodological Biases?

Balietti M, Giuli C, Conti F.

Mol Neurobiol. 2018 Aug;55(8):6661-6672. doi: 10.1007/s12035-017-0866-y. Epub 2018 Jan 13.

Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer's Disease

Wu Y, Li Z, Huang YY, Wu D, Luo HB.

J Med Chem. 2018 Jul 12;61(13):5467-5483. doi: 10.1021/acs.jmedchem.7b01370. Epub 2018 Feb 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias